Breaking Canadian GLP-1 news
GLP-1 News — Page 10
Drug approvals, price changes, generic timelines, and clinical trial results affecting GLP-1 medication costs in Canada.
Find my best option
Answer a few quick questions — get your cheapest path to a GLP-1 prescription, free.
Vimy Pharma Plans Canadian-Made Generic Semaglutide Filing
Vimy Pharma expects to file generic semaglutide application with Health Canada in coming weeks, joining nine other companies. Latest on GLP1Prices.ca
FDA Approves Oral Wegovy 25mg as First Weight Management Pill
FDA approved Novo Nordisk's oral Wegovy 25mg in December 2025 as first oral GLP-1 for weight management. Canadian approval timeline at GLP1Prices.ca
Generic Semaglutide to Test Canadian Employer Drug Budgets
Canadian employers face drug plan budget pressures as generic semaglutide launches mid-2026 with expected 65% price cuts. Coverage at GLP1Prices.ca
Alberta Blue Cross Delays Generic Semaglutide Launch to Mid-2026
Alberta Blue Cross reports generic semaglutide launch delayed until mid-2026, affecting employer drug plan cost relief expectations. Track updates at GLP1Prices.ca
Health Canada Tracker Shows 9 Generic Semaglutide Reviews
Health Canada's new public tracker reveals status of nine generic semaglutide applications under review, providing transparency - GLP1Prices.ca
Lilly Finds Impurity in Compounded Tirzepatide Products 2026
Eli Lilly reports impurities in compounded versions of tirzepatide, raising safety concerns for Canadian patients using non-authorized products. GLP1Prices.ca
Canada's Drug Agency to Decide Mounjaro Public Coverage
Provincial health plans await recommendation on Mounjaro coverage as assessment nears completion. Latest updates at GLP1Prices.ca
Novo Nordisk Forecasts Sales Slowdown from Generic Competition
Novo Nordisk officially acknowledges that generic semaglutide competition will slow Canadian sales growth as nine manufacturers prepare market entry. GLP1Prices.ca
Semaglutide Sales Hit $3.5 Billion in Canada During 2025
IQVIA Canada data reveals total 2025 semaglutide sales reached $3.5 billion across all brands as generic competition begins. Track prices at GLP1Prices.ca
Generic Semaglutide Production Begins in Canadian Facilities
Canadian pharmaceutical companies have started manufacturing generic versions of semaglutide following patent expiry. Track prices at GLP1Prices.ca
WHO Conditionally Recommends GLP-1s for Obesity Treatment 2026
World Health Organization issues conditional recommendation for GLP-1 therapies in obesity treatment, impacting Canadian regulatory decisions. GLP1Prices.ca
Felix Health Launches Generic Semaglutide Waitlist in Canada
Canadian telehealth provider Felix for Health opens waitlist for generic semaglutide as Health Canada reviews nine applications. GLP1Prices.ca
Health Canada Approves Wegovy for MASH Treatment in 2026
Health Canada issues Notice of Compliance for Wegovy semaglutide injection for MASH indication under NOC/c policy - GLP1Prices.ca
Novo Nordisk Launches Plosbrio and Poviztra Brands in Canada
Health Canada approves two new semaglutide brand names as Novo Nordisk expands product portfolio ahead of generic competition. GLP1Prices.ca
Generic Ozempic Could Cost 35% of Brand Price by End 2026
Industry experts project generic semaglutide will be priced at 35% of current Ozempic costs when it launches in Canada. Compare prices at GLP1Prices.ca
Health Canada Launches Public Generic Drug Submissions Tracker
Health Canada debuts online tracker showing status of generic drug applications under review, including semaglutide submissions. GLP1Prices.ca
Eli Lilly's Oral GLP-1 Drug Orforglipron Awaits Health Canada Review
Eli Lilly's new oral GLP-1 medication Orforglipron remains under review by Health Canada as of March 2026. Track GLP-1 drug developments at GLP1Prices.ca
Health Canada Reviews Suicide Risk with GLP-1 Medications
Health Canada examined potential risks of suicide and self-harm with GLP-1 receptor agonist medications in comprehensive safety review - GLP1Prices.ca
WHO Adds Semaglutide to Essential Medicines List 2026
World Health Organization designates semaglutide as essential medicine ahead of generic launches in Canada - GLP1Prices.ca
Eli Lilly Launches Redesigned Mounjaro KwikPen April 2026
Eli Lilly introduces updated Mounjaro KwikPen design in Canada starting April 2026, featuring enhanced injection mechanism - GLP1Prices.ca
Looking for current pharmacy prices?
Compare GLP-1 prices across Canada